Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Prospective, Randomized, Open Label Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin vs IV Ceftriaxone + IV Azithromycin Followed by PO Amoxicilline/Clavulanate and PO Clarithromycin in Subjects With Community-acquired Pneumonia

NCT00717561 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00717561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00717561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Prospective, Randomized, Open Label Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin vs IV Ceftriaxone + IV Azithromycin Followed by PO Amoxicilline/Clavulanate and PO Clarithromycin in Subjects With Community-acquired Pneumonia
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
June 30, 2009
Enrollment
60 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia